by GlobeNewsWire | Jul 5, 2016 | Globe Newswire
SILVER SPRING, Md., July 05, 2016 (GLOBE NEWSWIRE) — PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology,...
by GlobeNewsWire | Jul 5, 2016 | Globe Newswire
SOUTH SAN FRANCISCO, Calif., July 05, 2016 (GLOBE NEWSWIRE) — Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, announced that the U.S. Food...
by GlobeNewsWire | Jul 5, 2016 | Globe Newswire
BURLINGTON, Mass., July 05, 2016 (GLOBE NEWSWIRE) — ArQule, Inc. (Nasdaq:ARQL) today announced that Paolo Pucci, Chief Executive Officer, and Dr. Brian Schwartz, Chief Medical Officer and Head of Research and Development, will present at Cantor Fitzgerald’s 2nd...
by GlobeNewsWire | Jul 5, 2016 | Globe Newswire
San Francisco, July 05, 2016 (GLOBE NEWSWIRE) — The global neuroprosthetics market is expected to reach USD 14.6 billion by 2024, according to a new report by Grand View Research, Inc. The increasing prevalence of neurological disorders coupled with the demand...
by GlobeNewsWire | Jul 4, 2016 | Globe Newswire
Albany, NY, July 04, 2016 (GLOBE NEWSWIRE) — A research report on the global stem cells market, published by Transparency Market Research (TMR), estimates the market to record a healthy CAGR of 24.20% during the period from 2012 and 2018. In 2013, the market...